Purchase Order 75N92026P00035
- Not listed
- This federal contract award to 10X Genomics, Inc. was issued by the National Institute of Dental and Craniofacial Research (NIDCR), a component of the Department of Health and Human Services' National Institutes of Health (NIH). The $27,558 firm fixed price purchase order is for an add-on kit for a Xenium Analyzer, a specialized piece of scientific equipment used for cell segmentation analysis. This award is not associated with a larger contract vehicle and does not have a set-aside designation....
- The National Institute on Deafness and Other Communication Disorders, a civilian agency within the U.S. Department of Health and Human Services, awarded a $25,872.50 firm-fixed-price purchase order contract to 10X Genomics, Inc. for the delivery of 10X Genomics products. The contract has an ultimate completion date of September 30, 2024 and does not utilize any set-aside designations. The contract provides the agency with specialized kits, instruments, and associated services for applications...
- 10X Genomics, Inc. was awarded a $46,242.50 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Office of Logistics and Acquisition Operations. The contract calls for 10X Genomics to provide its genomics products and services from its Bethesda, Maryland location to support NIH's biomedical research efforts from September 2023 through September 2024. As a leading developer and manufacturer of single-cell analysis solutions, 10X Genomics...
- This is a firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $17,332.00 contract is for the delivery of 10X Genomics' products and services for single-cell and spatial analysis applications, including specialized kits, instruments, and associated installation, training, and support services. The contract has a period of...
- This contract award to 10X Genomics, Inc. (10X Genomics), a life sciences technology company, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health (NIH). The $23,773 firm fixed-price purchase order is for the delivery of 10X Genomics products and services to support biomedical research, including specialized kits for single-cell and spatial analysis techniques, as well as instruments and associated support services. The...
- This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services, to the prime contractor 10X Genomics, Inc. The $22,585.50 firm fixed price purchase order is for the acquisition of the Chromium GEM-X Single Cell 5' Kit, which will be used to support NIDDK's research initiatives. 10X Genomics, a life sciences technology company, provides a range of genomic analysis platforms, reagents,...
- This is a firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms and research tools. The contract is for the procurement of Chromium Next GEM Single Cell ATAC Kits and Chromium Next GEM Chip H Single Cell Kits, with a ceiling value of $24,910.17 and a period of...
- This is a firm fixed-price purchase order awarded by the National Institute of Dental and Craniofacial Research (NIDCR), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit biotechnology company. The $35,000.00 contract is for a Xenium Analyzer Service Plan, with a performance period ending on August 19, 2025. The contract does not have a set-aside designation. 10X Genomics is a leading provider of specialized genomic analysis platforms,...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a biotechnology company that specializes in advanced genomic analysis platforms, reagents, instruments, and bioinformatics software. The contract, valued at $24,608.17, is for the delivery of 10X Genomics Kits to support biomedical research at the NIH. The contract does not have a set-aside designation. 10X Genomics has been awarded numerous federal...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse awarded a Firm Fixed Price purchase order to 10X Genomics, Inc. (doing business as 10X Genomics) for $102,573.00. The contract is for the provision of specialized kits, instruments, and associated services for single-cell and spatial analysis applications to support biomedical research. As a prime contractor, 10X Genomics has previously provided similar products and services to...
The National Institute of Dental and Craniofacial Research awarded a $24,647 firm fixed-price purchase order to 10X Genomics, Inc. for 10X GEM-X Flex V2 sequencing services covering 96 samples. The contract was awarded on February 6, 2026, with an ultimate completion date of April 7, 2026, and will be performed in Bethesda, Maryland. This procurement was issued without a set-aside designation, allowing competition among all qualified contractors. The award represents a discrete analytical service delivery from 10X Genomics, a leading biotechnology company specializing in advanced genomic analysis platforms and single-cell transcriptomics technologies. 10X Genomics has established itself as a primary supplier of genomic research tools across the National Institutes of Health system since its federal contractor registration in July 2015. The company currently maintains significant indefinite delivery contracts with the National Institute on Aging ($7 million through July 2029) and the National Institute of Neurological Disorders and Stroke ($750,000), demonstrating sustained federal dependency on its specialized sequencing and reagent products. This purchase order aligns with the company's existing portfolio of federal contracts spanning tens of millions of dollars in aggregate value, supporting critical molecular research infrastructure across multiple NIH institutes and other civilian federal agencies.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
10X GEM-X Flex v2 sequencing, 96 samples | 75N92026Q00020 | Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute | Solicitation 1/1 | 1/27/26, 3:39 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.6k | 2/5/26 |